Caris Total Operating Expenses from 2010 to 2026
| CAI Stock | USD 25.00 0.55 2.15% |
Total Operating Expenses | First Reported 2006-03-31 | Previous Quarter 95.7 M | Current Value 114.9 M | Quarterly Volatility 25.2 M |
Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.8 M, Interest Expense of 33.1 M or Total Revenue of 497.8 M, as well as many indicators such as Price To Sales Ratio of 16.34, Dividend Yield of 0.0333 or Days Sales Outstanding of 175. Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
Caris | Total Operating Expenses | Build AI portfolio with Caris Stock |
Latest Caris Life's Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Caris Life Sciences over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Caris Life's Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caris Life's overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Caris Total Operating Expenses Regression Statistics
| Arithmetic Mean | 192,282,746 | |
| Geometric Mean | 112,982,454 | |
| Coefficient Of Variation | 101.13 | |
| Mean Deviation | 177,678,612 | |
| Median | 64,850,000 | |
| Standard Deviation | 194,446,318 | |
| Sample Variance | 37809.4T | |
| Range | 491.4M | |
| R-Value | 0.86 | |
| Mean Square Error | 10354.8T | |
| R-Squared | 0.74 | |
| Slope | 33,196,813 | |
| Total Sum of Squares | 604949.9T |
Caris Total Operating Expenses History
About Caris Life Financial Statements
Investors use fundamental indicators, such as Caris Life's Total Operating Expenses, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 501.3 M | 526.4 M |
Currently Active Assets on Macroaxis
When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:Check out the analysis of Caris Life Correlation against competitors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Trading Companies & Distributors space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caris Life. If investors know Caris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caris Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caris Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caris Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.